Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Milne

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 6, 2020
The MLL family of proteins in normal development and diseaseThomas A Milne
Blood|January 6, 2018
LEDGF: a leukemia-specific targetThomas A Milne
Haematologica|September 2, 2014
MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapyThomas A Milne
Blood|February 10, 2017
Mouse models of MLL leukemia: recapitulating the human diseaseThomas A Milne
Current Opinion in Genetics & Development|April 5, 2024
Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemiaThomas A Milne
Molecular & Cellular Oncology|June 17, 2016
Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteinsErica Ballabio, Thomas A Milne
Cancers|November 12, 2013
Molecular and Epigenetic Mechanisms of MLL in Human LeukemogenesisErica Ballabio, Thomas A Milne
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|April 8, 2025
Is Enhancer Function Driven by Protein-Protein Interactions? From Bacteria to LeukemiaNicholas T Crump, Thomas A Milne
Cell Chemical Biology|November 21, 2025
Small proteins with a big job: An EMBOW-derived microprotein targets WDR5-MLL1 and suppresses transcription in leukemiaHannah L Baillie, Thomas A Milne
Cellular and Molecular Life Sciences : CMLS|May 18, 2019
Why are so many MLL lysine methyltransferases required for normal mammalian development?Nicholas T Crump, Thomas A Milne
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 6, 2020
The MLL family of proteins in normal development and diseaseThomas A Milne
Blood|January 6, 2018
LEDGF: a leukemia-specific targetThomas A Milne
Haematologica|September 2, 2014
MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapyThomas A Milne
Blood|February 10, 2017
Mouse models of MLL leukemia: recapitulating the human diseaseThomas A Milne
Current Opinion in Genetics & Development|April 5, 2024
Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemiaThomas A Milne
Molecular & Cellular Oncology|June 17, 2016
Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteinsErica Ballabio, Thomas A Milne
Cancers|November 12, 2013
Molecular and Epigenetic Mechanisms of MLL in Human LeukemogenesisErica Ballabio, Thomas A Milne
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|April 8, 2025
Is Enhancer Function Driven by Protein-Protein Interactions? From Bacteria to LeukemiaNicholas T Crump, Thomas A Milne
Cell Chemical Biology|November 21, 2025
Small proteins with a big job: An EMBOW-derived microprotein targets WDR5-MLL1 and suppresses transcription in leukemiaHannah L Baillie, Thomas A Milne
Cellular and Molecular Life Sciences : CMLS|May 18, 2019
Why are so many MLL lysine methyltransferases required for normal mammalian development?Nicholas T Crump, Thomas A Milne
Pageof 10